View in EDS HTML Full Text PDF Full Text

Safety profiles of biosimilars vs. their EU reference products: INNs (adalimumab, bevacizumab, trastuzumab, rituximab, infliximab, etanercept).

Saved in:
Bibliographic Details
Title: Safety profiles of biosimilars vs. their EU reference products: INNs (adalimumab, bevacizumab, trastuzumab, rituximab, infliximab, etanercept).
Authors: Kopanarov, Valentin1 (AUTHOR), Benisheva, Tatyana1 (AUTHOR) benicheva_tb@yahoo.com, Naydenova, Radoslava1 (AUTHOR), Gergova, Veska1 (AUTHOR), Dimitrov, Dimitar1 (AUTHOR), Sidjimova, Dobriana1 (AUTHOR), Mateev, Hristo1 (AUTHOR)
Source: Biotechnology & Biotechnological Equipment. Dec2025, Vol. 39 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13102818
DOI:10.1080/13102818.2025.2529183